Evidence map›Paper›PMID 41302782›Full record

ArticleMicromachines2025

Intersession Robust Hybrid Brain-Computer Interface: Safe and User-Friendly Approach with LED Activation Mechanism.

Sefa Aydın, Mesut Melek, Levent Gökrem

Abstract read
In one paragraph

Article in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sefa AydınDepartment of Electronics and Automation, Gumushane University, Gumushane 29100, Turkey.ORCID 0000-0001-9965-2903
Mesut MelekDepartment of Software Engineering, Gumushane University, Gumushane 29100, Turkey.ORCID 0000-0002-7152-7788
Levent GökremDepartment of Electrical and Electronics Engineering, Tokat Gaziosmanpasa University, Tokat 60100, Turkey.ORCID 0000-0003-2101-5378

Funding

Türkiye Sağlık Enstitüleri Başkanlığı 36126
6 · The paper itself

Abstract

This study introduces a hybrid Brain-Computer (BCI) system with a robust and secure activation mechanism between sessions, aiming to minimize the negative effects of visual stimulus-based BCI systems on user eye health. The system is based on the integration of Electroencephalography (EEG) signals and Electrooculography (EOG) artefacts, and includes an LED stimulus operating at a frequency of 7 Hz for safe activation and objects moving in different directions. While the LED functions as an activation switch that reduces visual fatigue caused by traditional visual stimuli, moving objects provide command generation depending on the user's intention. In order to evaluate the stability of the system against physiological and psychological conditions, data were collected from 15 participants in two different sessions. The Correlation Alignment (CORAL) method was applied to the data to reduce the variance between sessions and to increase stability. A Bootstrap Aggregating algorithm was used in the classification processes, and with the CORAL method, the system accuracy rate was increased from 81.54% to 94.29%. Compared to similar BCI approaches, the proposed system offers a safe activation mechanism that effectively adapts to users' changing cognitive states throughout the day by reducing visual fatigue, despite using a low number of EEG channels, and demonstrates its practicality and effectiveness by performing on par or superior to other systems in terms of high accuracy and robust stability.

Indexed as

brain–computer interfaceclassificationcorrelation alignmentcross-sessionElectroencephalographyElectrooculography artefactsEmotiv Flexmachine learning

Identifiers

PMID41302782
PMCPMC12654623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.